Supraclavicular Brachial Plexus Block Using Ropivacaine Alone and With Dexmedetomidine

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
80 American Society of Anesthesiologists (ASA) grade I-II patients, 18-60 years old,scheduled for elective upper limb orthopaedic surgery under supraclavicular brachial plexus block, were included in this prospective study. The patients were randomly assigned to group R (Ropivacaine alone) and group RD (Ropivacaine and dexmedetomidine) (40 patients in each group). Group R received Ropivacaine 0.50% (30 cc) + placebo and group RD received Ropivacaine 0.50% (30 cc) + dexmedetomidine 1 µg/kg.
Epistemonikos ID: 0c87a510c3f073d50eb8c15eb1d63a7a509e4bc5
First added on: May 12, 2024